Skip to content

Clinical trials

Phase 2 Alzheimer Disease trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Country / region: Israel Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20161
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization2
Brainsway1
Neurim Pharmaceuticals Ltd.1
NeuroSense Therapeutics Ltd.1
Prothena Biosciences Ltd.1
Rutgers, The State University of New Jersey1
Tel-Aviv Sourasky Medical Center1
The Israeli Medical Center for Alzheimer's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease9
Cognitive Dysfunction2
Amyloidosis1
Dementia1
Immunoglobulin Light-chain Amyloidosis1
Metabolic Syndrome1
Paraproteinemias1
Parasomnias1
Sleep Wake Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.